Cargando…

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Detalles Bibliográficos
Autores principales: Blum, Vinicius Fontanesi, Cimerman, Sérgio, Hunter, James R, Tierno, Paulo, Lacerda, Acioly, Soeiro, Alexandre, Cardoso, Florentino, Bellei, Nancy Cristina, Maricato, Juliana, Mantovani, Nathalia, Vassao, Marcella, Dias, Danilo, Galinskas, Juliana, Janini, Luis Mário Ramos, Santos-Oliveira, Joanna Reis, Da-Cruz, Alda Maria, Diaz, Ricardo Sobhie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590842/
https://www.ncbi.nlm.nih.gov/pubmed/34805808
http://dx.doi.org/10.1016/j.eclinm.2021.101203
_version_ 1784599075423780864
author Blum, Vinicius Fontanesi
Cimerman, Sérgio
Hunter, James R
Tierno, Paulo
Lacerda, Acioly
Soeiro, Alexandre
Cardoso, Florentino
Bellei, Nancy Cristina
Maricato, Juliana
Mantovani, Nathalia
Vassao, Marcella
Dias, Danilo
Galinskas, Juliana
Janini, Luis Mário Ramos
Santos-Oliveira, Joanna Reis
Da-Cruz, Alda Maria
Diaz, Ricardo Sobhie
author_facet Blum, Vinicius Fontanesi
Cimerman, Sérgio
Hunter, James R
Tierno, Paulo
Lacerda, Acioly
Soeiro, Alexandre
Cardoso, Florentino
Bellei, Nancy Cristina
Maricato, Juliana
Mantovani, Nathalia
Vassao, Marcella
Dias, Danilo
Galinskas, Juliana
Janini, Luis Mário Ramos
Santos-Oliveira, Joanna Reis
Da-Cruz, Alda Maria
Diaz, Ricardo Sobhie
author_sort Blum, Vinicius Fontanesi
collection PubMed
description
format Online
Article
Text
id pubmed-8590842
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85908422021-11-15 Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981] Blum, Vinicius Fontanesi Cimerman, Sérgio Hunter, James R Tierno, Paulo Lacerda, Acioly Soeiro, Alexandre Cardoso, Florentino Bellei, Nancy Cristina Maricato, Juliana Mantovani, Nathalia Vassao, Marcella Dias, Danilo Galinskas, Juliana Janini, Luis Mário Ramos Santos-Oliveira, Joanna Reis Da-Cruz, Alda Maria Diaz, Ricardo Sobhie EClinicalMedicine Corrigendum Elsevier 2021-11-14 /pmc/articles/PMC8590842/ /pubmed/34805808 http://dx.doi.org/10.1016/j.eclinm.2021.101203 Text en © 2021 The Authors
spellingShingle Corrigendum
Blum, Vinicius Fontanesi
Cimerman, Sérgio
Hunter, James R
Tierno, Paulo
Lacerda, Acioly
Soeiro, Alexandre
Cardoso, Florentino
Bellei, Nancy Cristina
Maricato, Juliana
Mantovani, Nathalia
Vassao, Marcella
Dias, Danilo
Galinskas, Juliana
Janini, Luis Mário Ramos
Santos-Oliveira, Joanna Reis
Da-Cruz, Alda Maria
Diaz, Ricardo Sobhie
Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_full Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_fullStr Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_full_unstemmed Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_short Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
title_sort corrigendum to “nitazoxanide superiority to placebo to treat moderate covid-19 – a pilot prove of concept randomized double-blind clinical trial.” [eclinicalmedicine 37 (2021) 100981]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590842/
https://www.ncbi.nlm.nih.gov/pubmed/34805808
http://dx.doi.org/10.1016/j.eclinm.2021.101203
work_keys_str_mv AT blumviniciusfontanesi corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT cimermansergio corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT hunterjamesr corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT tiernopaulo corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT lacerdaacioly corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT soeiroalexandre corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT cardosoflorentino corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT belleinancycristina corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT maricatojuliana corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT mantovaninathalia corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT vassaomarcella corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT diasdanilo corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT galinskasjuliana corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT janiniluismarioramos corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT santosoliveirajoannareis corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT dacruzaldamaria corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981
AT diazricardosobhie corrigendumtonitazoxanidesuperioritytoplacebototreatmoderatecovid19apilotproveofconceptrandomizeddoubleblindclinicaltrialeclinicalmedicine372021100981